Surgical Science Sweden AB (publ) (STO:SUS)

STO:SUS Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	131.65	233.97	187.97	86.25	15.61
Depreciation & Amortization	60.52	38.4	35.66	23.9	10.25
Other Amortization	-	17.21	15.93	9.62	6.73
Other Operating Activities	10.95	-45.64	-44.46	-34	-3.52
Change in Accounts Receivable	-20.24	31.91	-70.76	-84.57	1.86
Change in Inventory	-11.56	-19.57	-21.72	6.46	-5.27
Change in Other Net Operating Assets	-34.09	-17.99	26.87	31.43	-2.43
Operating Cash Flow	137.23	238.29	129.49	39.08	23.23
Operating Cash Flow Growth	-42.41%	84.03%	231.31%	68.28%	-57.93%
Capital Expenditures	-6.1	-10.46	-9.35	-3.87	-0.4
Cash Acquisitions	-	-	-	-2,718	-
Sale (Purchase) of Intangibles	-41.43	-33.67	-25.2	-10.51	-8.3
Investing Cash Flow	-47.53	-44.13	-34.55	-2,733	-8.69
Long-Term Debt Issued	235.41	-	17.09	-	-
Long-Term Debt Repaid	-7.76	-3.3	-	-31.72	-5.14
Total Debt Repaid	-7.76	-3.3	-	-31.72	-5.14
Net Debt Issued (Repaid)	227.65	-3.3	17.09	-31.72	-5.14
Issuance of Common Stock	-	-	-	3,039	7.86
Other Financing Activities	-	19.15	-	-84.87	1.49
Financing Cash Flow	227.65	15.85	17.09	2,922	4.21
Foreign Exchange Rate Adjustments	16.44	-9.38	5.02	0.59	-0.8
Net Cash Flow	333.79	200.63	117.05	229.52	17.94
Free Cash Flow	131.12	227.84	120.14	35.21	22.83
Free Cash Flow Growth	-42.45%	89.65%	241.18%	54.26%	-58.41%
Free Cash Flow Margin	14.83%	25.81%	14.97%	9.60%	21.78%
Free Cash Flow Per Share	2.57	4.47	2.36	0.82	0.66
Cash Income Tax Paid	27.69	14.55	8.48	3.43	9.07
Levered Free Cash Flow	44.22	95.48	95.86	17.79	10.32
Unlevered Free Cash Flow	47.72	95.88	96.19	18.11	10.65
Change in Net Working Capital	58.65	35.16	18.88	52.89	10.99

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.